E

Edwards Lifesciences

11671 employees

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring.

Investor insights

Sectors invested in

Health Care6
Medical Device6
Biotechnology4
Medical3
Medical Devices2
Heart Failure2
Cardiology2
LAP Regulation2
Manufacturing2
Architecture2
Health Diagnostics2
Cardiovascular Disease1
Pharmaceutical1
Machine Learning1
Artificial Intelligence1
Deep Learning1
Medical Imaging1
AI1
Healthcare1

Funding rounds participated in

$22M sweet spot round size

Most of their 8 investments are in rounds between $3M and $50M

Basic info

Industry

medical equipment manufacturing

Sectors

Medical Device
Biotechnology
Heart Innovations
Enhanced Surgical Recovery
Heart Valve Technologies
Medical Devices
Quality Engineering
Structural Heart Disease
Anesthesia
Manufacturing
R&D Engineering
Health Care Technology
Heart Valves
Hospital Administration
Hemodynamic Monitoring
Surgical Monitoring
Vascular Catheters
Genuine Fogarty Catheters
Transcatheter Mitral &Tricuspid Therapies
Health Care
Critical Care
Medical
Medical Innovations
Heart Valve Therapies

Date founded

1958

Investments made

C

Caption Health raised $53M on July 15, 2020

Investors: LDV Partners, Atlantic Bridge Ventures LLP, K G Khosla compressors, Data Collective and Edwards Lifesciences

V

V-Wave raised $70M on April 27, 2018

Investors: Pura Vida Investments, Quark Venture, Triventures, BRM Group, Endeavour Vision, Pontifax Venture Capital, ISF Israel Secondary Fund and Edwards Lifesciences

V

V-Wave raised $28M on January 11, 2016

Investors: Pontifax Venture Capital, BRM Group, Pura Vida Investments, Triventures, BioStar Ventures and Edwards Lifesciences

C

Cardiokinetix raised $50M on December 8, 2014

Investors: Panorama Capital, Lexington Partners, New Leaf Venture Partners, SV Life Sciences and Edwards Lifesciences

M

Middle Peak Medical raised $3M on October 28, 2013

Investors: Wellington Partners, BioMedPartners, Seventure Partners and Edwards Lifesciences

U

Undisclosed raised $1.6M on October 1, 2009

Investors: BioStar Ventures and Edwards Lifesciences

V

Vascular Architects Inc. raised $6.6M on September 2, 2004

Investors: Three Arch Partners, VERTICAL, Domain Associates, Flare Capital, ARCH Venture Partners and Edwards Lifesciences

V

Vascular Architects Inc. raised $16M on January 6, 2003

Investors: Three Arch Partners, Domain Associates, VERTICAL, Flare Capital, ARCH Venture Partners and Edwards Lifesciences

FAQ